741 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study K.S. Lee,S.G. Lim,W.L. Chuang,S.G. Hwang,M. Cho,M.Y. Lai,Y.C. Chao,T.T. Chang, K.H. Han,C.M. Lee,S.H. Um,J.E. Yeon, S.S. Yang,E.K. Teo,C.Y. Peng,H.H. Lin,T.I. Huo,T. Nguyen,T.Y. Chen, K.Q. Hu,Y. Xu,J.Z. Sullivan-Bólyai, K.S. LeeJOURNAL OF HEPATOLOGY（2006）引用 15|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
